| For: | Nasa P, Chaudhary S, Shrivastava PK, Singh A. Euglycemic diabetic ketoacidosis: A missed diagnosis. World J Diabetes 2021; 12(5): 514-523 [PMID: 33995841 DOI: 10.4239/wjd.v12.i5.514] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v12/i5/514.htm |
| Number | Citing Articles |
| 1 |
Soumya Shanta Mohanty, R. R. Selvammathy, Hindustan Abdul Ahad, Edukulla Satheesh Kumar. Combined use of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors for cardiovascular protection. Indian Journal of Pharmacology 2026; 58(4) doi: 10.4103/ijp.ijp_1384_25
|
| 2 |
Andreas M. Nieß, Ansgar Thiel. Körperliche Aktivität und Trainingstherapie bei Typ-2-Diabetes – ein Update. Diabetologie und Stoffwechsel 2024; 19(01) doi: 10.1055/a-1797-4949
|
| 3 |
Jonathan S. Auerbach, Hayley B. Gershengorn, Oscar D. Aljure, Joseph Lamelas, Samira S. Patel, Tanira D. Ferreira, Lazaro A. Gonzalez, Jorge L. Cabrera. Postcardiac Surgery Euglycemic Diabetic Ketoacidosis in Patients on Sodium-Glucose Cotransporter 2 Inhibitors. Journal of Cardiothoracic and Vascular Anesthesia 2023; 37(6) doi: 10.1053/j.jvca.2023.01.041
|
| 4 |
Rakahn Haddadin, Danny Aboujamra, Homayon Iraninezhad. Sodium-Glucose Cotransporter-2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis in a Type 2 Diabetic Patient. Cureus 2023; doi: 10.7759/cureus.51184
|
| 5 |
Wiktoria Bińczyk, Olgierd Dróżdż, Bartosz Siudek, Agnieszka Głuszczyk, Jakub Plizga, Filip Grajnert. The significance of precise diabetes diagnosis: a case of euglycemic diabetic ketoacidosis induced by the introduction of empagliflozin with simultaneous reduction of insulin dosage. European Journal of Case Reports in Internal Medicine 2024; 11(6) doi: 10.12890/2024_004567
|
| 6 |
Marutheesh Mallappa, Gayathri K Reddy, Murali Jayaraman. Euglycemic Diabetic Ketoacidosis—A Rare Cause for Delayed Extubation: Case Report. Indian Journal of Critical Care Case Report 2024; 3(3) doi: 10.5005/jp-journals-11006-0105
|
| 7 |
Walter Yaw Agyeman, Inemesit Akpan, Kwasi Opare-Addo, Saheed Soleye, Alfred Solomon. Euglycemic Diabetic Ketoacidosis in a Patient Post Cardiac Surgery Receiving Continuous Renal-Replacement Therapy. Annals of Internal Medicine: Clinical Cases 2023; 2(10) doi: 10.7326/aimcc.2023.0663
|
| 8 |
Angelina Anthamatten. Important Dietary Considerations for Sodium-Glucose Cotransporter 2 Inhibitors. The Journal for Nurse Practitioners 2023; 19(3) doi: 10.1016/j.nurpra.2022.104527
|
| 9 |
Subodh Verma, Sunder Mudaliar, Peter J. Greasley. Potential Underlying Mechanisms Explaining the Cardiorenal Benefits of Sodium–Glucose Cotransporter 2 Inhibitors. Advances in Therapy 2024; 41(1) doi: 10.1007/s12325-023-02652-5
|
| 10 |
Sukhjinder Chauhan, AndreyI Manov, Gundip S Dhillon, Pinak Shah. Empagliflozin-Associated Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes Mellitus. Cureus 2023; doi: 10.7759/cureus.33892
|
| 11 |
Irina Balan, V Lakshmi N Priyanka Ganapathiraju, Sudha Dirisanala, Shafaq Taj, Pratikkumar Vekaria. Case Report: Euglycemic diabetic ketoacidosis led by empagliflozin: A case report and literature review. F1000Research 2022; 11 doi: 10.12688/f1000research.127382.1
|
| 12 |
Anna E. Garcia Whitlock, Henry D. Seidel, James W. Suliburk. Principles of Adult Surgical Critical Care. 2026; doi: 10.1007/978-3-032-22660-0_32
|
| 13 |
Murat Dagdeviren, Tolga Akkan, Derun Taner Ertugrul. Re-emergence of a forgotten diabetes complication. Turkish Journal of Emergency Medicine 2024; 24(1) doi: 10.4103/tjem.tjem_110_23
|
| 14 |
Luis F Gonzalez Vazquez, Angel Diaz Sanchez, Yelka Matos Furones, Paola Vanessa Sosa Sarmiento, Jose I Gamboa Arisso, Elizabeth Blanco Espinosa. Euglycemic Diabetic Ketoacidosis Presenting With Intraoperative Cardiac Arrest in Late Pregnancy. Cureus 2026; doi: 10.7759/cureus.106959
|
| 15 |
Kyosuke Takahashi, Norimichi Uenishi, Masamitsu Sanui, Shigehiko Uchino, Naoki Yonezawa, Tetsuhiro Takei, Norihiro Nishioka, Hirotada Kobayashi, Shunichi Otaka, Kotaro Yamamoto, Hideto Yasuda, Shintaro Kosaka, Hidehiko Tokunaga, Naoki Fujiwara, Takashiro Kondo, Tomoki Ishida, Takayuki Komatsu, Koji Endo, Taiki Moriyama, Takayoshi Oyasu, Mineji Hayakawa, Atsumi Hoshino, Tasuku Matsuyama, Yuki Miyamoto, Akihiro Yanagisawa, Tadamasa Wakabayashi, Takeshi Ueda, Tetsuya Komuro, Toshiro Sugimoto, Alan Kawarai Lefor. Clinical profile of patients with diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome in Japan: a multicenter retrospective cohort study. Acta Diabetologica 2023; 61(1) doi: 10.1007/s00592-023-02181-1
|
| 16 |
Waiz Wasey, Sarah Hutchings, Anastasia Dufner, Dorathy Okon, Sharefi Saleh. Fall, Fracture, and Two Episodes of Euglycemic Diabetic Ketoacidosis. Cureus 2022; doi: 10.7759/cureus.25788
|
| 17 |
Feras Al-Moussally, Jung-Jung Tien, Kanya Rajagopalan, Carlos Boterosuarez, Roger Crouse. Euglycemic Ketoacidosis and Lactic Acidosis Associated With Metformin Toxicity. Cureus 2024; doi: 10.7759/cureus.60661
|
| 18 |
Laura Roberson, June Yao, Christina So, Brian Tuai. Hidden risk of euglycemic diabetic ketoacidosis with sodium-glucose cotransporter 2 (SGLT2) inhibitors in emergency general surgery in the United States: a case report. Journal of Acute Care Surgery 2026; 16(1) doi: 10.17479/jacs.2025.0021
|
| 19 |
Inass Shaltout, Amr Mahmoud Abdelwahab, Amr El Meligi, Hany Hammad, Shereen Abdelghaffar, Atef Elbahry, Nasser Taha, Nehal Hamdy Elsaid, Amr Gad, Laila Hammouda, Shaymaa Abdelmaboud, Amin Roshdy Soliman. Risk Stratification in People with Diabetes for Fasting During Ramadan:
Consensus from Arabic Association for the Study of Diabetes and
Metabolism. Current Diabetes Reviews 2024; 20(7) doi: 10.2174/0115733998249793231005105724
|
| 20 |
Kripa Tiwari, Nava R Sharma, Madalasa Pokhrel, Arjun Basnet, Michael Kaplan. Misleading Presentation: Chest Pain Masking Euglycemic Diabetic Ketoacidosis Possibly Induced by Empagliflozin. Cureus 2023; doi: 10.7759/cureus.49402
|
| 21 |
Paul S. Pagel, Dustin Hang, Julie K. Freed, George J. Crystal. Advances in Cardiovascular Pharmacotherapy. IV. Sodium-Glucose Cotransporter Type 2 Inhibitors, Part 2: Mechanisms for Myocardial Protection, Adverse Effects, and Perioperative Implications. Journal of Cardiothoracic and Vascular Anesthesia 2025; 39(11) doi: 10.1053/j.jvca.2025.06.015
|
| 22 |
Shejil Kumar, Terrence Diamond. Ramadan Fasting and Maternal and Fetal Outcomes in Pregnant Women with Diabetes Mellitus: Literature Review. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.900153
|
| 23 |
Shahd M. Abbas, Fajr Jamal A.bagi, Asmaa Abdalkarim, Nematalla Sabir Balla, Amro Abdelrahman, Khalid Y Fadul. Case Report: Chest Pain as an Uncommon Presentation for Euglycemic Diabetic Ketoacidosis in a Female Patient Using SGLT2 inhibitor. F1000Research 2024; 12 doi: 10.12688/f1000research.139928.2
|
| 24 |
Aijin Niu, Jing Zhuang, Yangdi Li, Wei Wei. Construction and validation of nomogram prediction model for ketoacidosis in elderly diabetic patients based on baseline data and glycolipid metabolism. Journal of Diabetes Investigation 2025; 16(7) doi: 10.1111/jdi.70058
|
| 25 |
Ying Xun, Wenqing Zeng. Ketogenic metabolic therapy: low-carbohydrate interventions as novel neuroprotective strategies for cognitive dysfunction in diabetes. Frontiers in Aging Neuroscience 2026; 18 doi: 10.3389/fnagi.2026.1777834
|
| 26 |
Věra Čertíková Chábová, Oskar Zakiyanov. Sodium Glucose Cotransporter-2 Inhibitors: Spotlight on Favorable Effects on Clinical Outcomes beyond Diabetes. International Journal of Molecular Sciences 2022; 23(5) doi: 10.3390/ijms23052812
|
| 27 |
Erica Chow, Stephen Clement, Rajesh Garg. Euglycemic diabetic ketoacidosis in the era of SGLT-2 inhibitors. BMJ Open Diabetes Research & Care 2023; 11(5) doi: 10.1136/bmjdrc-2023-003666
|
| 28 |
Cameron Widhalm, Victor Pulido. Euglycemic Diabetic Keto Acidosis in a Type 1 Diabetic Patient After Glucose Like Peptide-1 Administration: A Case Presentation. Journal of Investigative Medicine High Impact Case Reports 2023; 11 doi: 10.1177/23247096231206333
|
| 29 |
Christy C. Greenhalgh, Amy Bigham, Tonya D. Shanahan. A Case Study of Euglycemic Diabetic Ketoacidosis. Advanced Emergency Nursing Journal 2025; 47(2) doi: 10.1097/TME.0000000000000562
|
| 30 |
Mei-An Pai, Tsai-Kun Wu, Shiaw-Wen Chien, Chang-Hsu Chen, Yuan-Chuan Kuo, Hung-Ping Chen, Tien-Yu Tseng, Paik-Seong Lim. Euglycemic diabetic ketoacidosis associated with sodium–glucose cotransporter-2 inhibitors after surgery: A case report and review of literature. Tungs' Medical Journal 2023; 17(2) doi: 10.4103/ETMJ.ETMJ-D-23-00018
|
| 31 |
José Ginestal-Calvo, J.L. Flordelís-Lasierra, J.L. Pérez-Vela, Laura Campos-Bermejo, Cristian Coso-Garrido, Luis Blanco-Carrasco, Carmen Galiano-Carrilero, Helena Domínguez-Aguado, Emilio Renes-Carreño. Postoperative Ketoacidosis in Cardiac Surgery: Incidence, Analytical Profile, and Association With Sodium-Glucose Cotransporter 2 Inhibitors—A Prospective Observational Study. Journal of Cardiothoracic and Vascular Anesthesia 2026; 40(2) doi: 10.1053/j.jvca.2025.11.014
|
| 32 |
Ivona Vranić, Ivan Stanković, Miloš Panić, Predrag Miličević, Aleksandar Nešković. Empagliflozin-associated euglycemic ketoacidosis. Srce i krvni sudovi 2022; 41(4) doi: 10.5937/siks2204186V
|
| 33 |
Yuichiro Arima. The Impact of Ketone Body Metabolism on Mitochondrial Function and Cardiovascular Diseases. Journal of Atherosclerosis and Thrombosis 2023; 30(12) doi: 10.5551/jat.RV22011
|
| 34 |
Matthew F Hillock, Cierra Jarmon, Anastasia E Metropulos, Rachael King, Stefan Tchernodrinski, Daniel R Principe. Diabetic ketoacidosis masked by both Euglycemia and a primary metabolic alkalosis. Oxford Medical Case Reports 2024; 2024(7) doi: 10.1093/omcr/omae071
|
| 35 |
Barbara Meitner-Schellhaas, Thomas Haak. Ketoazidose bei SGLT2-Hemmer-Therapie. Diabetes aktuell 2025; 23(04) doi: 10.1055/a-2588-6302
|
| 36 |
N. Silvestris, T. Franchina, M. Gallo, A. Argentiero, A. Avogaro, G. Cirino, A. Colao, R. Danesi, G. Di Cianni, S. D’Oronzo, A. Faggiano, S. Fogli, D. Giuffrida, S. Gori, N. Marrano, R. Mazzilli, M. Monami, M. Montagnani, L. Morviducci, A. Natalicchio, A. Ragni, V. Renzelli, A. Russo, L. Sciacca, E. Tuveri, M.C. Zatelli, F. Giorgino, S. Cinieri. Diabetes management in cancer patients. An Italian Association of Medical Oncology, Italian Association of Medical Diabetologists, Italian Society of Diabetology, Italian Society of Endocrinology and Italian Society of Pharmacology multidisciplinary consensus position paper. ESMO Open 2023; 8(6) doi: 10.1016/j.esmoop.2023.102062
|
| 37 |
Audrey K. Cook, Ellen Behrend. SGLT2 inhibitor use in the management of feline diabetes mellitus. Journal of Veterinary Pharmacology and Therapeutics 2025; 48(S1) doi: 10.1111/jvp.13466
|
| 38 |
Minju Kim, Jiyoon Bhan, Do Gyeong Lee, Hyun Sik Chung. SGLT-2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis Masked by Concurrent Pneumoperitoneum Following Spinal Surgery Under General Anesthesia: A Case Report. Journal of Clinical Medicine 2026; 15(16) doi: 10.3390/jcm15166145
|
| 39 |
Zhaoxiang Liu, Luqi Xiao, Chenxi Jin, Jianzhong Xiao, Wenhui Zhao. Euglycaemic Ketoacidosis Due to Extremely Low-Calorie Intake and Dehydration After Laparoscopic Sleeve Gastrectomy in a Patient with Type 2 Diabetes. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2022; doi: 10.2147/DMSO.S373712
|
| 40 |
Beng Leong Lim, Kee Vooi Loo, Wei Feng Lee. Euglycemic diabetic ketoacidosis: pitfalls, challenges, and perspectives in emergency medicine. European Journal of Emergency Medicine 2025; 32(2) doi: 10.1097/MEJ.0000000000001189
|
| 41 |
Teodora Mateoc, Andrei-Luca Dumitrascu, Corina Flangea, Daniela Puscasiu, Tania Vlad, Roxana Popescu, Cristina Marina, Daliborca-Cristina Vlad. SGLT2 Inhibitors: From Structure–Effect Relationship to Pharmacological Response. International Journal of Molecular Sciences 2025; 26(14) doi: 10.3390/ijms26146937
|
| 42 |
Azeem Rathore, Nidhi Gupta, Cameron Kahn. Euglycemic diabetic ketoacidosis caused by Empagliflozin complicated by failure to thrive in a geriatric patient. Archive of Clinical Cases 2023; 10(2) doi: 10.22551/2023.39.1002.10248
|
| 43 |
Barbara Meitner-Schellhaas, Thomas Haak. Ketoazidose bei SGLT2-Hemmer-Therapie. Diabetologie und Stoffwechsel 2025; 20(01) doi: 10.1055/a-2368-0280
|
| 44 |
Esraa Mamdouh Hassan, Hisham Mushtaq, Esraa Elaraby Mahmoud, Sherley Chhibber, Shoaib Saleem, Ahmed Issa, Jain Nitesh, Abbas B Jama, Anwar Khedr, Sydney Boike, Mikael Mir, Noura Attallah, Salim Surani, Syed A Khan. Overlap of diabetic ketoacidosis and hyperosmolar hyperglycemic state. World Journal of Clinical Cases 2022; 10(32): 11702-11711 doi: 10.12998/wjcc.v10.i32.11702
|
| 45 |
Brannon Inman, Joseph K. Maddry, Patrick C. Ng, Alex Koyfman, Brit Long. High risk and low prevalence diseases: Toxic alcohol ingestion. The American Journal of Emergency Medicine 2023; 67 doi: 10.1016/j.ajem.2023.01.048
|
| 46 |
Jingjing Han, Shuo Xie, Hongmei Jiao. Sodium‐glucose cotransporter‐2 inhibitor‐induced euglycemic diabetic ketoacidosis: A case report. Journal of Clinical Pharmacy and Therapeutics 2022; 47(9) doi: 10.1111/jcpt.13737
|
| 47 |
Alice Huang, Jenny Lu, Nicole Pancotto, Gagandeep S Sekhon, Isabel M Gossen, July M Reyes, Roxana Lazarescu. Unmasking Euglycemic Diabetic Ketoacidosis: The Interplay of Pregnancy, Sepsis, and Glucagon-Like Peptide 1 Analog. Cureus 2025; doi: 10.7759/cureus.78193
|
| 48 |
Dimitra Stathi, Florence Ning Lee, Mili Dhar, Stergios Bobotis, Elisavet Arsenaki, Taruna Agrawal, Konstantinos Katsikas Triantafyllidis, Konstantinos S Kechagias. Diabetic Ketoacidosis in Pregnancy: A Systematic Review of the Reported Cases. Clinical Medicine Insights: Endocrinology and Diabetes 2025; 18 doi: 10.1177/11795514241312849
|
| 49 |
Ankia Coetzee, David R. Hall, Eduard J. Langenegger, Mari van de Vyver, Magda Conradie. Pregnancy and diabetic ketoacidosis: fetal jeopardy and windows of opportunity. Frontiers in Clinical Diabetes and Healthcare 2023; 4 doi: 10.3389/fcdhc.2023.1266017
|
| 50 |
Yousun An, Nicholas Norris, Donglai Li, Jenny E. Gunton. Ketogenic Diet in Obesity and Diabetes: A Narrative Review. Nutrients 2026; 18(12) doi: 10.3390/nu18122004
|
| 51 |
. Rizwanullah, Tahera Ahmadi, Aftab Ahmad, Waqar Khan, Jose C Rosario-Curcio. Euglycemic Diabetic Ketoacidosis With Acute Renal Failure: A Challenging Case for Clinicians. Cureus 2024; doi: 10.7759/cureus.60171
|
| 52 |
Yiwei Huang, Xinyuan Yu, Changxin Li. Sodium–Glucose Cotransporter 2 Inhibitors: An Emerging Therapeutic Approach for Ischemic Stroke Management. CNS Drugs 2025; 39(12) doi: 10.1007/s40263-025-01230-3
|
| 53 |
Nevin Kamal, Kristen Lee, Grazia Aleppo. Newer Outpatient Diabetes Therapies and Technologies. Medical Clinics of North America 2024; 108(5) doi: 10.1016/j.mcna.2024.03.002
|
| 54 |
Vania Benido Silva, Liliana Fonseca, Diana Borges Duarte, Francisca Marques Puga, Guilherme Assuncao, Susana Garrido, Sofia Teixeira, Joana Vilaverde, Maria Helena Cardoso. Efficacy and safety of SGLT2 inhibitors in individuals with type 1 diabetes under continuous subcutaneous insulin infusion: a real-world study. Endocrine Regulations 2023; 57(1) doi: 10.2478/enr-2023-0018
|
| 55 |
Said S. Tarraf, William J. Weir, Kevin R. Olsen. Euglycemic diabetic ketoacidosis in a neurosurgical patient on empagliflozin: a case report. Journal of Neurocritical Care 2025; 18(2) doi: 10.18700/jnc.250033
|
| 56 |
Tiffany Corlin, Sereen K. Nashif, Katelyn M. Tessier, Megan Kristan, W. Kirke Rogers, Sarah A. Wernimont. Opportunities to Improve Recognition of Diabetic Ketoacidosis in Pregnancy. O&G Open 2024; 1(4) doi: 10.1097/og9.0000000000000035
|
| 57 |
Evan J. Chen, William A. West, Kavitha Bagavathy, Chiara Lazzeri. A Case of Euglycemic Ketoacidosis Secondary to Continuous Renal Replacement Therapy. Case Reports in Critical Care 2025; 2025(1) doi: 10.1155/crcc/6275218
|
| 58 |
Arnon Gal, Adesola Odunayo. Diabetes Ketoacidosis and Hyperosmolar Hyperglycemic Syndrome in Companion Animals. Veterinary Clinics of North America: Small Animal Practice 2023; 53(3) doi: 10.1016/j.cvsm.2023.01.005
|
| 59 |
Dimitra Stathi, Ketan K. Dhatariya, Omar G. Mustafa. Management of diabetes‐related hyperglycaemic emergencies in advanced chronic kidney disease: Review of the literature and recommendations. Diabetic Medicine 2025; 42(2) doi: 10.1111/dme.15405
|
| 60 |
Huaxi Zou, Baiquan Qiu, Jichun Liu. Alexander et al.: Longer-Term Effects of SGLT2Is. Journal of General Internal Medicine 2022; 37(11) doi: 10.1007/s11606-022-07655-6
|
| 61 |
Yee Wen Kong, Dale Morrison, Jean C. Lu, Melissa H. Lee, Alicia J. Jenkins, David N. O'Neal. Continuous ketone monitoring: Exciting implications for clinical practice. Diabetes, Obesity and Metabolism 2024; 26(S7) doi: 10.1111/dom.15921
|
| 62 |
Enrique Chicote-Álvarez, Helena Camino-Ferró, Isabel Mainar-Gil, Lucía Ángela Vilella-Llop, Mirian Ruiz de la Cuesta-López, Natalia Gloria Lizama-Gómez. Cetoacidosis diabética euglucémica en paciente gestante con infección por SARS-CoV-2: reporte de caso. Acta Colombiana de Cuidado Intensivo 2023; 23(1) doi: 10.1016/j.acci.2022.09.002
|
| 63 |
Gao Wu, Shuxie Wu, Jin Tang, Hanbin Wu. Delayed euDKA Associated With Dapagliflozin After Pancreatitis. Clinical Therapeutics 2023; 45(7) doi: 10.1016/j.clinthera.2023.05.006
|
| 64 |
Fiona Bensoussan, Guillaume Costa, Anne Blanchard, Isabelle Vaugier, Stéphanie Baron, Aben Essid, Blaise Mbieleu, Awa Bakayoko, Nicolas Deconinck, Jean Bergounioux, Justine Zini. Paradoxical metabolic acidosis after vomiting in children with spinal muscular atrophy: A report of 9 patients. Archives de Pédiatrie 2024; 31(7) doi: 10.1016/j.arcped.2024.03.010
|
| 65 |
Luminita-Georgeta Confederat, Alin-Constantin Pînzariu, Ionela Lacramioara Serban, Mihaela-Iustina Condurache, Oana-Maria Dragostin. SGLT2 Inhibitors Between Benefits and Euglycemic Ketoacidosis: A Concise Review. International Journal of Molecular Sciences 2026; 27(12) doi: 10.3390/ijms27125224
|
| 66 |
Jessica Warffuel, Linda Barbour, Shannon Son. Diabetic Ketoacidosis and Euglycemic Diabetic Ketoacidosis in Pregnancy. Topics in Obstetrics & Gynecology 2024; 44(3) doi: 10.1097/01.PGO.0001006384.17611.04
|
| 67 |
Beda M. Cha, Roland Davoudi, Michael C. DiVita, Ashley M. Fan, Megan Y. Kamath. Sodium-Glucose Cotransporter-2 Inhibitor–Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report. Transplantation Proceedings 2021; 53(8) doi: 10.1016/j.transproceed.2021.08.017
|
| 68 |
Rohit Kumar Tiwari, Afza Ahmad, Muskan Chadha, Kingshuk Saha, Harshitha Verma, Kalpojit Borgohain, Ratnakar Shukla. Modern-Day Therapeutics and Ongoing Clinical Trials against Type 2 Diabetes Mellitus: A Narrative Review. Current Diabetes Reviews 2024; 21(6) doi: 10.2174/0115733998294919240506044544
|
| 69 |
Bobbi-Jo Lowie, Michael C. Bond. Diabetic Ketoacidosis. Endocrinology and Metabolism Clinics of North America 2026; 55(1) doi: 10.1016/j.ecl.2025.02.002
|
| 70 |
Madison S Meyer, Sushmithaa Ramesh, Yasmine Rammouni, Shoshanah Lasry, Hasan Sawan, Khalid Zakaria. Early-Onset Euglycemic Diabetic Ketoacidosis Following Empagliflozin Initiation Triggered by Acute Influenza and a Ketogenic Diet. Cureus 2026; doi: 10.7759/cureus.114227
|
| 71 |
Sajid Hasanali Mukaddam, Hasan Mohammed Tooblani, Riya Gupta. Life-threatening dapagliflozin-associated euglycaemic diabetic ketoacidosis in a postoperative patient. BMJ Case Reports 2025; 18(1) doi: 10.1136/bcr-2024-260473
|
| 72 |
John C. Rowe, Morgan Scaglione, Marwan Ma'ayeh, George Saade. Diagnosis and Management of Euglycemic Diabetic Ketoacidosis in Pregnancy. Obstetrics & Gynecology 2026; 147(3) doi: 10.1097/AOG.0000000000006143
|
| 73 |
Faical Jarraya, Abdou Niang, Hussein Bagha, Elliot Koranteng Tannor, Ernest Kiswaya Sumaili, Davy Ip Min Wan, Mogamat-Yazied Chothia, Yewondwossen Tadesse Mengistu, Francois Folefack Kaze, Ifeoma Isabella Ulasi, Saraladevi Naicker, Mohamed Hany Hafez, Kouame Hubert Yao. The Role of Sodium-Glucose Cotransporter-2 Inhibitors in the Treatment Paradigm of CKD in Africa: An African Association of Nephrology Panel Position Paper. Kidney International Reports 2024; 9(3) doi: 10.1016/j.ekir.2023.12.019
|
| 74 |
Paul Richard Edwin Jarvis. Euglycemic diabetic ketoacidosis: a potential pitfall for the emergency physician. Clinical and Experimental Emergency Medicine 2023; 10(1) doi: 10.15441/ceem.22.410
|
| 75 |
Maximus Kyung Hyun Lee, Perry A. Ball. Euglycemic diabetic ketoacidosis in the setting of acute intracerebral hemorrhage. Surgical Neurology International 2024; 15 doi: 10.25259/SNI_295_2024
|
| 76 |
William P. Martin, Niamh Reidy, Justin Low, Tomás Ahern. Case Report: Diabetic ketoacidosis after co-administration of empagliflozin and probenecid. Wellcome Open Research 2024; 8 doi: 10.12688/wellcomeopenres.19148.2
|
| 77 |
Udo Hoss, Shridhara Alva, Heather Pryor, Zoe Welsh, Benjamin Feldman. Continuous Dual Glucose–Ketone Sensing Technology. Diabetes Technology & Therapeutics 2025; 27(S4) doi: 10.1177/15209156251390820
|
| 78 |
Zhichao He, Kakei Lam, Wenxia Zhao, Shan Yang, Yu Li, Jiayao Mo, Siyuan Gao, Dan Liang, Kaifeng Qiu, Min Huang, Junyan Wu. SGLT-2 inhibitors and euglycemic diabetic ketoacidosis/diabetic ketoacidosis in FAERS: a pharmacovigilance assessment. Acta Diabetologica 2022; 60(3) doi: 10.1007/s00592-022-02015-6
|
| 79 |
João Fustiga, Marco Fernandes, Francisca Dâmaso, Joana A Duarte, Catarina Rodrigues. Postop Complication With Euglycemic Diabetic Ketoacidosis in a Patient Receiving Empagliflozin. Cureus 2022; doi: 10.7759/cureus.33161
|
| 80 |
Xiaoqing Xu, Dayang Wang, Huichai Pan, Jun Li, Bowu Li, Zhongchen He. Ketonuria in an adult with Prader-Willi syndrome and diabetes mellitus: A case report. Medicine 2024; 103(4) doi: 10.1097/MD.0000000000037096
|
| 81 |
Benjamin Cohen, Yael Tobi Harris, Rifka Schulman-Rosenbaum. Sodium-Glucose Cotransporter 2 Inhibitors Should Be Avoided for the Inpatient Management of Hyperglycemia. Endocrine Practice 2024; 30(4) doi: 10.1016/j.eprac.2023.11.014
|
| 82 |
José Paz-Ibarra, Juan Eduardo Quiroz-Aldave, María del Carmen Durand-Vásquez, Luis Alberto Concepción-Urteaga, Rommy Díaz Quispe, Marcio José Concepción-Zavaleta. Primer caso reportado en Perú de cetoacidosis euglicémica por inhibidor del cotransportador de sodio glucosa tipo 2. Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo 2025; 18(1) doi: 10.35434/rcmhnaaa.2025.181.2677
|
| 83 |
Beatrice C. Lupsa, Richard G. Kibbey, Silvio E. Inzucchi. Ketones: the double-edged sword of SGLT2 inhibitors?. Diabetologia 2023; 66(1) doi: 10.1007/s00125-022-05815-1
|
| 84 |
Dahyeon Lee, Gayeong Seo, Yunha Kim, Jea Young Min, Jeong Yee. Clinical features and outcomes of diabetic ketoacidosis in patients using SGLT2 inhibitors: A systematic review and meta‐analysis. Diabetes, Obesity and Metabolism 2025; 27(10) doi: 10.1111/dom.16635
|
| 85 |
Bianca-Liana Grigorescu. Dubito ergo sum. Pathologies that can mimic sepsis. The Journal of Critical Care Medicine 2022; 8(2) doi: 10.2478/jccm-2022-0011
|
| 86 |
Sehui Kim, Dae-Lim Jee, Suyoun Chun, Jongyoon Baek. Utility of Partitioning of Standard Base Excess in Euglycemic Diabetic Ketoacidosis with Hyperchloremic Acidosis. Keimyung Medical Journal 2024; 43(1) doi: 10.46308/kmj.2023.00248
|
| 87 |
Patricia Lunet Marques, Beatriz Mendoza, Maria Joana Dias, Miguel Carvalho, Stijn M. Niessen, Rodolfo Oliveira Leal. Clinical Management of Euglycemic Ketoacidosis in a Cat With Congenital Diabetes Mellitus Treated With Insulin and Dapagliflozin. Journal of Veterinary Emergency and Critical Care 2025; 35(2) doi: 10.1111/vec.13458
|
| 88 |
Adnan Zaina, Nunzia Prencipe, Elena Golden, Alessandro Maria Berton, Eldad Arad, Ali Abid, Jeryes Shehadeh, Sameer Kassem, Ezio Ghigo. How to position sodium-glucose co-transporter 2 inhibitors in the management of diabetes in acromegaly patients. Endocrine 2023; 80(3) doi: 10.1007/s12020-023-03352-4
|
| 89 |
Hsiao-Hui Ju. Euglycemic Diabetic Ketoacidosis. Critical Care Nursing Clinics of North America 2025; 37(1) doi: 10.1016/j.cnc.2024.08.004
|
| 90 |
Mohamad Ahangar Davoodi, Mohammad Ali Daneshmand, Taraneh Rezaei. Are sodium‐glucose cotransporter‐2 inhibitors safe adjunctive drugs during insulin therapy in young children with type 1 diabetes? The first case of type 1 diabetes with SLC5A2 mutation. Journal of Diabetes 2024; 16(7) doi: 10.1111/1753-0407.13570
|
| 91 |
Ofek Raviv, Nimra Tejeda, Issa Ali, Osama Khan, Jared Piotrkowski. A Rare Case of Euglycemic Diabetic Ketoacidosis: Triad of Influenza A, Methicillin-Susceptible Staphylococcus aureus Pneumonia, and Sodium-Glucose Co-transporter 2 Inhibitor Use. Cureus 2025; doi: 10.7759/cureus.90882
|
| 92 |
Guillermo E. Umpierrez, Georgia M. Davis, Nuha A. ElSayed, Gian Paolo Fadini, Rodolfo J. Galindo, Irl B. Hirsch, David C. Klonoff, Rozalina G. McCoy, Shivani Misra, Robert A. Gabbay, Raveendhara R. Bannuru, Ketan K. Dhatariya. Hyperglycemic Crises in Adults With Diabetes: A Consensus Report. Diabetes Care 2024; 47(8) doi: 10.2337/dci24-0032
|
| 93 |
Ravi Shukla, Puja Shrestha, Binod Khanal, Bipal Regmi. Euglycemic Diabetic Ketoacidosis: Clinical Suspicion and Diagnosis. Clinical Medicine Insights: Endocrinology and Diabetes 2026; 19 doi: 10.1177/11795514261431390
|
| 94 |
Guillermo E. Umpierrez, Georgia M. Davis, Nuha A. ElSayed, Gian Paolo Fadini, Rodolfo J. Galindo, Irl B. Hirsch, David C. Klonoff, Rozalina G. McCoy, Shivani Misra, Robert A. Gabbay, Raveendhara R. Bannuru, Ketan K. Dhatariya. Hyperglycaemic crises in adults with diabetes: a consensus report. Diabetologia 2024; 67(8) doi: 10.1007/s00125-024-06183-8
|
| 95 |
Caroline Wojtas, Alex P. Rasarmos, Naja Naddaf, Wayne V. Moore. Sodium-Glucose Transport Protein 2 Inhibitors Association with Euglycemic Diabetic Ketoacidosis. Case Reports in Endocrinology 2023; 2023 doi: 10.1155/2023/6835882
|
| 96 |
Bibek Devkota, Timothy Maxwell, Jessica Schaedel, Brant M Wagener, Weifeng Song, Nishank Patel Nooli. Intraoperative Diagnosis of Sodium-Glucose Transporter-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis. Cureus 2024; doi: 10.7759/cureus.71931
|
| 97 |
Ivana Novaković, Jovana Todorović, Stefan Dugalić, Maja Macura, Miloš Milinčić, Miroslava Gojnić. Diabetic ketoacidosis in pregnancy. Sanamed 2024; 19(2) doi: 10.5937/sanamed0-50195
|
| 98 |
Almurtada Razok, Fateen Ata, Sara Mohamed Ibrahim Ahmed, Dabia Hamad S H Al Mohanadi. Sodium-glucose co-transporter 2 inhibitors induced euglycemic diabetic ketoacidosis within four days of initiation. World Journal of Diabetes 2022; 13(3): 272-274 doi: 10.4239/wjd.v13.i3.272
|
| 99 |
Myrem Jesame F Sarno, Dan Philip F Hernandez, Melgar O Matulac. "Normal but Catastrophic” Euglycemic Diabetic Ketoacidosis Precipitated by Sodium-Glucose Cotransporter-2 Inhibitor Use: A Case Report. Cureus 2023; doi: 10.7759/cureus.49236
|
| 100 |
Andrijana Koceva, Nika Aleksandra Kravos Tramšek. From Sweet to Sour: SGLT-2-Inhibitor-Induced Euglycemic Diabetic Ketoacidosis. Journal of Personalized Medicine 2024; 14(7) doi: 10.3390/jpm14070665
|
| 101 |
Jonathan S. Auerbach, Ahmed Alnajar, Samira S. Patel, Hayley B. Gershengorn, Joseph Lamelas, Daitiara Perez, Oscar D. Aljure, Tanira D. Ferreira, Lazaro A. Gonzalez, Jorge L. Cabrera. Retrospective Chart Review of Euglycemic Diabetic Ketoacidosis Rates and Outcomes Postimplementation of Sodium Glucose Cotransporter 2 Inhibitor Use Stoppage 5 Days Before Open Heart Surgery. Journal of Cardiothoracic and Vascular Anesthesia 2025; 39(6) doi: 10.1053/j.jvca.2025.02.030
|
| 102 |
Keishi Yamauchi. Euglycemic Diabetic Ketoacidosis-Like State During the Treatment of Diabetic Ketoacidosis in Fulminant Type 1 Diabetes: A Case Report. Cureus 2026; doi: 10.7759/cureus.106472
|
| 103 |
Hesham Yasin, Jordan D. Ross, James Turner, Samuel Dagogo-Jack. Euglycemic Diabetic Ketoacidosis in a Pregnant Patient on Insulin Pump Therapy. AACE Clinical Case Reports 2025; 11(1) doi: 10.1016/j.aace.2024.10.004
|
| 104 |
Jens Aberle, Matthias Blüher, Matthias Laudes, Martin Merkel, Petra Sandow. SGLT-2-Inhibitoren – Eine Standortbestimmung in der deutschen oralen Therapielandschaft für Menschen mit Typ-2-Diabetes. Diabetologie und Stoffwechsel 2025; 20(01) doi: 10.1055/a-2435-6818
|
| 105 |
Benjamin Steinhorn, Jeanine Wiener-Kronish. Dose-dependent relationship between SGLT2 inhibitor hold time and risk for postoperative anion gap acidosis: a single-centre retrospective analysis. British Journal of Anaesthesia 2023; 131(4) doi: 10.1016/j.bja.2023.06.063
|
| 106 |
Yonas Wondie, Awoke Minwuyelet, Alemwork Dessalegn Bogale, Getachew Hailu, Emiru Ayalew Mengstie. Risk factors of diabetic ketoacidosis among patients with diabetes attending at public hospitals of East Gojjam Zone, Northwest Ethiopia: an unmatched case - control study. BMC Endocrine Disorders 2025; 25(1) doi: 10.1186/s12902-025-02023-x
|
| 107 |
Jinyoung Kim, Yeoree Yang, Chaiho Jeong, Ba-Ron Yang, Mee Kyoung Kim, Seung-Hwan Lee, Ki-Ho Song. Case 11: A 31-Year-Old Woman With Abdominal Pain. Journal of Korean Medical Science 2023; 38(23) doi: 10.3346/jkms.2023.38.e206
|
| 108 |
Antoine Hedary, Lacie Melder, Micah Pippin . A Case of Euglycemic Diabetic Ketoacidosis Associated With a Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor. Cureus 2024; doi: 10.7759/cureus.75399
|
| 109 |
Carol F. Kirkpatrick, Anandita Agarwala, Kevin C. Maki. How low should one go in reducing carbohydrate?. Journal of Clinical Lipidology 2022; 16(6) doi: 10.1016/j.jacl.2022.10.007
|
| 110 |
Mackenzi Meier, Benedicta Ansong, Dolapo Awobusuyi, Raven Lee-Oyagha, Sarah Lopez. Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitor-Related Euglycemic Diabetic Ketoacidosis: A Case Series. Journal of Pharmacy Practice 2025; 38(1) doi: 10.1177/08971900241273169
|
| 111 |
Revital Nimri, Keren Smuel-Zilberberg, Michal Yackobovitch-Gavan, Rachel Bello, Naama Fisch-Shvalb, Sari Krepel Volsky, Moshe Phillip. Twenty-Five Hours of Fasting with Automated Insulin Delivery in Youth with Type 1 Diabetes. Diabetes Technology & Therapeutics 2026; 28(6) doi: 10.1177/15209156251407705
|
| 112 |
Antonia-Therese Kietaibl, Peter Fasching, Karl Glaser, Alexander H. Petter-Puchner. New Diabetic Medication Sodium-Glucose Cotransporter-2 Inhibitors Can Induce Euglycemic Ketoacidosis and Mimic Surgical Diseases: A Case Report and Review of Literature. Frontiers in Surgery 2022; 9 doi: 10.3389/fsurg.2022.828649
|
| 113 |
Lamiz Tannouri, Shahinaz Gouda, Youssef Abboud. A Case of Euglycemic Diabetic Ketoacidosis in Patient with Type 2 DM. Open Journal of Emergency Medicine 2023; 11(04) doi: 10.4236/ojem.2023.114017
|
| 114 |
Carmela Morace, Giuseppe Lorello, Federica Bellone, Cristina Quartarone, Domenica Ruggeri, Annalisa Giandalia, Giuseppe Mandraffino, Letteria Minutoli, Giovanni Squadrito, Giuseppina T. Russo, Herbert Ryan Marini. Ketoacidosis and SGLT2 Inhibitors: A Narrative Review. Metabolites 2024; 14(5) doi: 10.3390/metabo14050264
|
| 115 |
Nadeem Rais, Rizwan Ahmad, Akash Ved, Kehkashan Parveen, Darakhshan Gazala Bari, Om Prakash. Diabetic Ketoacidosis (DKA), a Leading Risk Factor for Mucormycosis
(Black Fungus), during the Era of Coronavirus Disease-2019 (COVID-19):
An Overview. Current Diabetes Reviews 2023; 19(1) doi: 10.2174/1573399818666220315162424
|
| 116 |
Emil Sergejuk, Wojciech Kotlarski, Klaudia Magdalena Kotlarska, Tomasz Mainka. SODIUM-GLUCOSE COTRANSPORTER-2 INHBITORS AND THE RISK OF EUGLYCEMIC DIABETIC KETOACIDOSIS: A NARRATIVE REVIEW. International Journal of Innovative Technologies in Social Science 2026; 4(2(50)) doi: 10.31435/ijitss.2(50).2026.5543
|
| 117 |
W. Kirke Rogers, Iryna Chugaieva, Amir Moheet, Sarah A. Wernimont. Diabetes Mellitus in Pregnancy: Implications for Obstetric Anesthesia. Anesthesiology 2025; 143(2) doi: 10.1097/ALN.0000000000005534
|
| 118 |
Naina Mohamed Pakkir Maideen, Sulthan Al Rashid, Rajkapoor Balasubramanian, Deepika Vishwanathan, Arun Shanmugam. Euglycemic Diabetic Ketoacidosis in the Era of SGLT2 Inhibitors: Epidemiology, Mechanisms, Diagnosis, Prevention, and Future Perspectives. SN Comprehensive Clinical Medicine 2026; 8(1) doi: 10.1007/s42399-026-02540-3
|
| 119 |
Christopher D VonTungeln, Mohammad Al Bataineh. Euglycemic Diabetic Ketoacidosis Induced by Sodium-Glucose Cotransporter-2 Inhibitor Use and Coronary Angiography: A Case Report. Cureus 2024; doi: 10.7759/cureus.52122
|
| 120 |
Niyati Patel, Anvit Reddy, Kaitlyn N Romero, Pramod Reddy. Euglycemic Diabetic Ketoacidosis in the Setting of Dulaglutide Use. Cureus 2025; doi: 10.7759/cureus.82143
|
| 121 |
Shahd M. Abbas, Fajr Jamal A.bagi, Asmaa Abdalkarim, Nematalla Sabir Balla, Amro Abdelrahman, Khalid Y Fadul. Case Report: Chest Pain as an Uncommon Presentation for Euglycemic Diabetic Ketoacidosis in a Female Patient Using SGLT2 inhibitor. F1000Research 2023; 12 doi: 10.12688/f1000research.139928.1
|
| 122 |
Daniel Unzueta Ortiz, Mariel Alejandra Hernández Gutiérrez, Jesús Elías Díaz Mendoza, Julio César Corral González. Cetoacidosis diabética euglucémica en un paciente con choque séptico secundario a infección por Rickettsia typhi: a propósito de un caso. Medicina Crítica 2024; 38(7) doi: 10.35366/119538
|
| 123 |
Megha Gupta, Shipra Tawade, Ahmed Shah Nazari, Ritesh Joshi. Stress-Induced Transient Diabetic Ketoacidosis (DKA) in Pregnancy Without Pre-existing Diabetes. Cureus 2025; doi: 10.7759/cureus.99575
|
| 124 |
Alhassan Hassan. Severe Euglycemic Ketoacidosis Secondary to Tirzepatide Use for Weight Loss. Cureus 2026; doi: 10.7759/cureus.107028
|
| 125 |
Zulma Cardona, Jared G. Friedman, Nevin Kamal, Diana J. Oakes, Amisha Wallia, Grazia Aleppo, Sophia Brown, Courtney T. Makowski, Kyle Ritter, Emily D. Szmuilowicz. Developing a Protocol for Management of Euglycemic Diabetic Ketoacidosis. Current Diabetes Reports 2025; 25(1) doi: 10.1007/s11892-025-01604-3
|
| 126 |
Fatemeh Mohammadzade, Behnaz Khodabakhshi, Elahe Amiri, Amir Bigdeli, Fahimeh Abdollahi, Alireza Fatemi. Euglycemic diabetic ketoacidosis and COVID‐19 management in a term pregnant patient; a case report. Clinical Case Reports 2022; 10(12) doi: 10.1002/ccr3.6705
|
| 127 |
Yu. V. Bykov. Euglycemic diabetic ketoacidosis: Current understanding of pathogenesis, diagnosis, and treatment. FOCUS. Endocrinology 2026; 7(1) doi: 10.62751/2713-0177-2026-7-1-04
|
| 128 |
Johannes Nienhaus, Theresa Tenge, Sophia Riesemann, Detlef Kindgen-Milles, Giovanna Lurati Buse, René MʼPembele, Sebastian Roth. Natrium-Glukose-Co-Transporter-2 (SGLT-2)-Hemmer in der perioperativen Medizin. Die Anaesthesiologie 2025; 74(10) doi: 10.1007/s00101-025-01580-z
|
| 129 |
Rabia Salman Mahfooz, Muhammad Khuzzaim Khan, Hussam Al Hennawi, Anwar Khedr. SGLT-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis: A Case Report and a Literature Review . Cureus 2022; doi: 10.7759/cureus.26267
|
| 130 |
Sukhjinder Chauhan, Victoria Diaz, Ikechukwu R Ogbu, Justin Roy P Sanchez, Andre E Manov, Pinak Shah. Empagliflozin-Associated Euglycemic Diabetic Ketoacidosis Masked by Urinary Tract Infection. Cureus 2024; doi: 10.7759/cureus.66408
|
| 131 |
Muhammad Sameer Arshad, Adeena Jamil, Stephen J. Greene, Harriette G.C Van Spall, Gregg C. Fonarow, Javed Butler, Muhammad Shahzeb Khan. In-hospital initiation of sodium-glucose co-transporter-2 inhibitors in patients with acute heart failure. Heart Failure Reviews 2024; 30(1) doi: 10.1007/s10741-024-10446-2
|
| 132 |
Bobbi-Jo Lowie, Michael C. Bond. Diabetic Ketoacidosis. Emergency Medicine Clinics of North America 2023; 41(4) doi: 10.1016/j.emc.2023.06.002
|
| 133 |
Emmanuel Israel Edache, Adamu Uzairu, Paul Andrew Mamza, Gideon Adamu Shallangwa, Muhammad Tukur Ibrahim. Design of some potent non-toxic Autoimmune disorder inhibitors based on 2D-QSAR, CoMFA, molecular docking, and molecular dynamics investigations. Intelligent Pharmacy 2024; 2(5) doi: 10.1016/j.ipha.2023.12.009
|
| 134 |
Pengqiang Du, Xiaoyu Chen, Yinpeng Xu, Yujie Zhou, Hongli Gao. Drug‐Associated Ketoacidosis: A Comprehensive Disproportionality Analysis Based on the FAERS Database. Diabetes, Obesity and Metabolism 2026; 28(7) doi: 10.1111/dom.70790
|